Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.
Learn how Schneck Medical Center focused efforts to improve care for COPD patients, resulting in an 80 percent reduction in the unplanned COPD readmission rate and hundreds of thousands of dollars in savings. ...read more
Jon Aquino, Corporate Chief Quality and Vice Compliance Officer at AHMC Healthcare shares his experience with using Watson Health solutions to support quality improvement efforts in the sepsis patient population. ...read more